Timber Pharmaceuticals, Inc., along with its affiliates, filed a motion for joint administration of their Chapter 11 bankruptcy cases in the US Bankruptcy Court on November 19, 2023. As per the motion, the debtor seeks the joint administration of the cases of its affiliates, BioPharmX, Inc., with its own case for administrative and procedural purposes. Timber Pharmaceuticals, Inc. has been proposed as the lead debtor.